These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 11342006)
21. Regulated expression of an insulin-responsive glucose transporter (GLUT4) minigene in 3T3-L1 adipocytes and transgenic mice. Ezaki O; Flores-Riveros JR; Kaestner KH; Gearhart J; Lane MD Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3348-52. PubMed ID: 8475079 [TBL] [Abstract][Full Text] [Related]
22. The antidiabetic agent pioglitazone increases expression of glucose transporters in 3T3-F442A cells by increasing messenger ribonucleic acid transcript stability. Sandouk T; Reda D; Hofmann C Endocrinology; 1993 Jul; 133(1):352-9. PubMed ID: 8319581 [TBL] [Abstract][Full Text] [Related]
23. Indinavir uncovers different contributions of GLUT4 and GLUT1 towards glucose uptake in muscle and fat cells and tissues. Rudich A; Konrad D; Török D; Ben-Romano R; Huang C; Niu W; Garg RR; Wijesekara N; Germinario RJ; Bilan PJ; Klip A Diabetologia; 2003 May; 46(5):649-58. PubMed ID: 12712244 [TBL] [Abstract][Full Text] [Related]
24. Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. Sakurai K; Kawazuma M; Adachi T; Harigaya T; Saito Y; Hashimoto N; Mori C Br J Pharmacol; 2004 Jan; 141(2):209-14. PubMed ID: 14707028 [TBL] [Abstract][Full Text] [Related]
25. Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes. Bazuine M; Carlotti F; Tafrechi RS; Hoeben RC; Maassen JA Mol Endocrinol; 2004 Jul; 18(7):1697-707. PubMed ID: 15184525 [TBL] [Abstract][Full Text] [Related]
27. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Garvey WT; Maianu L; Hancock JA; Golichowski AM; Baron A Diabetes; 1992 Apr; 41(4):465-75. PubMed ID: 1535055 [TBL] [Abstract][Full Text] [Related]
28. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes. Yamaguchi S; Katahira H; Ozawa S; Nakamichi Y; Tanaka T; Shimoyama T; Takahashi K; Yoshimoto K; Imaizumi MO; Nagamatsu S; Ishida H Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E643-9. PubMed ID: 15928020 [TBL] [Abstract][Full Text] [Related]
29. YM268 increases the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes. Shimaya A; Kurosaki E; Shioduka K; Nakano R; Shibasaki M; Shikama H Horm Metab Res; 1998 Sep; 30(9):543-8. PubMed ID: 9808320 [TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. Stephens JM; Lee J; Pilch PF J Biol Chem; 1997 Jan; 272(2):971-6. PubMed ID: 8995390 [TBL] [Abstract][Full Text] [Related]
31. The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro. Müller G; Wied S Diabetes; 1993 Dec; 42(12):1852-67. PubMed ID: 8243832 [TBL] [Abstract][Full Text] [Related]
32. Signaling pathways through which insulin regulates CCAAT/enhancer binding protein alpha (C/EBPalpha) phosphorylation and gene expression in 3T3-L1 adipocytes. Correlation with GLUT4 gene expression. Hemati N; Ross SE; Erickson RL; Groblewski GE; MacDougald OA J Biol Chem; 1997 Oct; 272(41):25913-9. PubMed ID: 9325324 [TBL] [Abstract][Full Text] [Related]
33. Annexin II is a thiazolidinedione-responsive gene involved in insulin-induced glucose transporter isoform 4 translocation in 3T3-L1 adipocytes. Huang J; Hsia SH; Imamura T; Usui I; Olefsky JM Endocrinology; 2004 Apr; 145(4):1579-86. PubMed ID: 14726447 [TBL] [Abstract][Full Text] [Related]
34. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. Stephens JM; Pekala PH J Biol Chem; 1991 Nov; 266(32):21839-45. PubMed ID: 1939208 [TBL] [Abstract][Full Text] [Related]
35. Isoproterenol inhibits cyclic AMP-mediated but not insulin-mediated translocation of the GLUT4 glucose transporter isoform. Macaulay SL; Kelada AS; Proietto J Mol Cell Biochem; 1994 Dec; 141(1):27-33. PubMed ID: 7877606 [TBL] [Abstract][Full Text] [Related]
36. GLUT4 facilitates insulin stimulation and cAMP-mediated inhibition of glucose transport. Lawrence JC; Piper RC; Robinson LJ; James DE Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3493-7. PubMed ID: 1314390 [TBL] [Abstract][Full Text] [Related]
37. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes. Ishibashi KI; Imamura T; Sharma PM; Huang J; Ugi S; Olefsky JM J Clin Invest; 2001 May; 107(9):1193-202. PubMed ID: 11342583 [TBL] [Abstract][Full Text] [Related]
38. Effect of vanadate on glucose transporter (GLUT4) intrinsic activity in skeletal muscle plasma membrane giant vesicles. Kristiansen S; Youn J; Richter EA Biochim Biophys Acta; 1996 Jun; 1282(1):71-5. PubMed ID: 8679662 [TBL] [Abstract][Full Text] [Related]
39. High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes. Nelson BA; Robinson KA; Buse MG Diabetes; 2000 Jun; 49(6):981-91. PubMed ID: 10866051 [TBL] [Abstract][Full Text] [Related]
40. Mechanism of pervanadate stimulation and potentiation of insulin-activated glucose transport in rat adipocytes: dissociation from vanadate effect. Shisheva A; Shechter Y Endocrinology; 1993 Oct; 133(4):1562-8. PubMed ID: 8404595 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]